Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Crazy day.. now over mil on the ask!
Got out of Genspera but when FLG took over thought that they would advance mipsagargin so got back in but they took a different path with L&C. Since the merger with L&C the stock has done less than zero and everyone is on the side lines waiting for something to happen. FLG is gone now so hard to predict if anything will come of this ticker!
Whiteydutch..that's a handle I haven't heard since Genspera days. A takeover or sale or merger or any of the above would be welcomed by most of us at this point!
Locked and loaded...any positive news will send this ticker up. Slaps on the ask with good volume is on the way!
DD,price action, chart, rsi and recent filings are all providing signals that a major breakout is on its way. Not if it will happen only when!
Why would Mike Cain take on the positions at nspx on an "at-will" status with no-compensation? Also, what does an IT guy have that brings credence to a biotech? Strange developments in continuing saga! Still can't fathom why Lowe and FLG would leave NSPX without some score to put into their resume.
Possible! But if not a buyout a partnership/licensing/collaboration/merger because of NSPX amount of IP is certainly likely going forward!
10-Q for 2nd quarter 2019 due wed (14). Great time to catch up on all filings. Has taken too long!
Probably makes little difference but new management always gives some thinking that situations may improve. Lowe and FLG Partners (unless there is something in the works) did very little to improve value. Lowe has been virtually silent for over two years as the PPS keep falling into the sub pennies. Very poor performance but that is just my opinion (the stock price is ALWAYS the report card on management).
I don't believe the sticker will be revoked as long as they are making an effort (although it may seem feeble)to get current. However, until they finally get current with SEC reporting anything may happen!
market makers playing their little games! Can't stand the chance to miss messing with gun shy investors.
No follow thru after a promising start to the day. Just treading water until filings/news /updates/anything comes from NSPX. Like to think that something will come out prior to the 2nd quarter 10-Q due in a few weeks. Hold tight things may move fast!
2nd quarter 2019 10-Q is due mid august. Lets think that all filings will be up to date by then!
Some brave soul layed out $ 4.00 for a stake in Nspx! Must know somethings coming!
A fight between 4 and 3..which one will be taken out first? Continued silence maybe 3 .. updates and getting current.. bye bye 4!!
4 is a great place to be as things will surely heat up!
I believe that the cards will be turned and Lowe et al will finally give some direction where this is going. FLG and Lowe have been in charge since march 2016. GNSZ/NSPX has been around since 2003. You would think that it is time for something positive to happen for all involved!
Very possible scenario! The intriguing question is what is the mipsagargin patent worth? Its obvious the NSPX does not have the financial resources to move the trials forward but NSPX/genspera has spent millions developing mipsagargin and I dont think they would let it go for peanuts!
Any positive news concerning moving forward with mipsagargin would certainly benefit. Also some cash flow from partner Ridgeway and/or further partnering agreements would eliminate some financial pressure . A outright sale is always possible. Anything is on the table and as of now its totally up in the air!
i like that mini flag pattern on the daily
hitting the ask..time to move up!
4 of the 6 delinquent filings are submitted. 10-K for 2018 and 10-Q for quarter 1 2019 still out. 3 weeks before 7/5 proposed deadline to have them submitted. Seems like NSPX is serious about getting current!
I would think that the last filings to get current would meet that proposed date. However NZPX cant seem to get any act together.. see post #4590 dated 1/24/19. Some strange happenings in this ticker for sure. Maxed out AS and waiting for BOOM!
its a spec position that can go either way Pal..if i wanted a sure thing i would have bought shares in berkshire hathaway!
Its held so far but with the low volume anything may happen. No real action just waffling along waiting for something to happen!
Hard to think that the remaining 3 filings (10-Q quarter 3 2018, 10-K 2018 and 10-Q quarter 1 2019) would be difficult to put together since the amount of activity of the company. Should be able to get current by the imposed July 5 date or before!
In Feb 2018 CEO (Lowe) shuts everything down. Lays off all employees including L&C including labs and renowned Phd Thompson. Pulls the plug on further mipsagargin studies. No website, no office, no sec reporting, No clinical trials or studies. Virtually out of business! Yet Sabby loans thru debentures 500K in July. (nice to have friends with money).
Reasons for R/S in 14D 1. Increase PPS to “encourage interest and trading” (ya right) and 2. “Meet obligations of our outstanding debentures”. However neither work very well without some major positive news concerning the status of the drug portfolio! A PPS increase may be forthcoming so hold on!
The purchase agreement 7/3/18 specified raising authorized shares to cover shares in debentures. Why the change to a R/S?
Barring any further extensions your post sounds reasonable!
Interesting to see if 30 holds as part of a double bottom. In a holding pattern waiting on updates.
Very quiet and oversold so a bounce is certainly possible!
Chris Lowe (CFO@ Cortexyme) still signing as CEO of Nspx. Interesting to see when current if he and/or FLGPARTNERS will still be involved. So far haven’t done much for Nspx since taking over in 2016. A financial “expert” that ran the company out of money and shut down operations. A shell company trying to peddle patents.. there is value in them for the right situation moving forward!
Investors extended date to get current to July 5. See F-24 of recent filing! That gives Nspx another couple of months to catch up on all the delinquent filings!
Nspx tried to move up but too many weak hands! Sellers can stand any prosperity!
Nspx been oversold since last Monday.. bounce is due! Needs to squeeze some of them shorts!
Ha! Good to see after a not so great week! Great to start the weekend with a little chuckle!
Tens of millions were spent on development of mipsagargin. Yes further development was halted for unspecified reasons but that does not mean mipsagargin is worthless and/or dead! The lack of funding/partner for a ph III trial is disappointing but that is now but other ongoing studies may change things!
Ha! Double bottom maybe but not trips! To much going for nspx to stay down long! A bundle of patents that will prove their worth! Sellers in charge now but that can change quickly!
We’re in penny stock land..there is or seems to be an endless supply of weak hands that will sell! Nspx needs to come thru with a valid reason to buy which they haven’t come up with yet!